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The cochlea, a part of the auditory system, is a complex structure consisting of several 
different types of cells including hair cells and spiral ganglion neurons. In mammals, the 
regenerative potential of hair cells and spiral ganglion neurons is lost soon after the birth and 
damage to any of these cells causes sensorineural hearing loss. Cochlear implant is presently 
the only available treatment for sensorineuronal hearing loss, bypassing the malfunctioning 
hair cells and directly simulating the spiral ganglion neurons. Cochlear implant functionality 
depends on the activation of remaining spiral ganglion neurons. A possibility for a stem cell 
approach replacing auditory neurons in the cochlea has attracted great interest. The aim of 
this thesis was to identify methods to induce progenitors for sensory neurons from human 
pluripotent stem cells, with the prospective use in a cell therapy for the inner ear.  
Paper I focused on differentiation of sensory neural types from precursors at different stages 
of neural rosette formation derived from human embryonic stem cells (day 4, 7, or 11-
rosettes). Neural and sensory neural phenotype differentiation was examined by 
immunocytochemistry. Cells positive for NESTIN and TUJ1 were present at all tested time 
points, indicating presence of the earliest stages of neural differentiation. Starting from the 
11-days neural rosettes resulted in decreased potential for neural differentiation, compared to 
starting from the 4-and 7-days protocols which more effectively could be driven into 
differentiation towards cells with sensory neuron marker phenotype. 
In paper II an approach using the SB431542 small molecule for blocking of the 
TGFß/Activin/Nodal signaling pathway was evaluated for effects on sensory neural 
differentiation, examined by gene expression and immunocytochemistry. Blocking of this 
pathway significantly facilitated the induction of markers present on sensory neurons; NGN1, 
NEUROD1 and BRN3A. Consecutive treatment with bFGF further enhanced the expression 
of these markers, as well as an increase in expression of GATA3. This protocol also enhanced 
the presence of colonies positive for TUJ1 as well as BRN3A or ISL1. Notably, addition of a 
third culture step, with exposure to the neurotrophic factors BDNF + NT3 resulted in > 90% 
presence of colonies with a phenotype compatible with sensory neurons. 
In paper III, we evaluated the capacity of additional small molecules (Isoxazole-9 and 
Metformin) to induced sensory neurons, starting from long-term neuroepithelial stem (lt-
NES) cells. Here, Isoxazole 9 (ISX9), but not Metformin or SB431542, significantly induced 
sensory neural genes (GATA3, BRN3A and PERIPHERIN) after a 4-day treatment. Exposure 
to ISX9 significantly increased the number of BRN3A/TUJ1 positive cells. Further treatment 
with BDNF7NT3 resulted in increased levels of cells with GATA3 expression and also 
BRN3A/TUJ1 positive cells in ISX9-exposed populations.  
In conclusion, this thesis has explored and demonstrated cultural conditions for in vitro 
induction of sensory neural phenotypes, starting from in vitro cultured human pluripotent 
stem cells or lt-NES cells. The presented approaches may provide appropriate strategies to 
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1 INTRODUCTION 
1.1 HEARING LOSS 
Hearing impairment is one of the most common disabilities. It is associated with poor quality 
of life of the affected individuals, which can only be partly restored using traditional hearing 
aids. Therefore, it is of great importance for an individual to maintain intact hearing 
throughout life. According to WHO, it is estimated that 360 million people have disabling 
hearing loss. Hearing impairment is broadly classified as conductive or sensorineural hearing 
loss, based on the affect part of the ear (Figure 1).  
Conductive hearing loss is a condition when sound is not conducted efficiently to the inner 
ear through the outer or/and middle ear. It involves reduction of the loudness of sound or 
ability to hear faint sounds. Conductive hearing loss is usually a result of anatomical 
deformations of the outer or middle ear, diseases of the outer or middle ear like tumors, ear 
infections, earwax or damage to the tympanic membrane and the presence of fluid in the 
middle ear. Conductive impairment can be treated either by hearing aids to normalize the 
sound range, or antibiotics or surgery to overcome defects in the outer or middle ear.    
 
Figure 1: Anatomy of human ear. Modified from Noback, 2005. 
Sensorineural hearing loss is the most common type of hearing disability. It is a condition 
caused by damage to cells in inner ear (cochlea) or the cochlear nerve, which connects the 
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cochlea to the brainstem. Sensorineural hearing loss, caused by malfunctioning hair cells or 
spiral ganglion neurons in the cochlea, involves the lack of ability to convert mechanical 
sound waves to electrical signals, or the electrical signals to activate cell in the auditory 
brainstem. The loss of hair cells and/or spiral ganglion neurons is permanent in mammals. 
The most common cause is age-related changes, ototoxic drugs, noise exposure, genetic 
factors, infections or neuropathy. Unlike conductive hearing loss, treatment options are very 
limited in sensorineural hearing loss. Cochlear implants are currently the only available 
option to treat, at least partially, sensorineural hearing loss. The cochlear implant provides 
electrical stimulation that acts directly on the spiral ganglion cells, thus bypassing the 
damaged or lost hair cells.  
1.1.1 Inner ear 
The inner ear is fluid-filled structure located within the temporal bone of the skull. It is 
composed of the cochlea and the vestibular system, the sensory organs for hearing and 
balance, respectively. The two systems are separate but enclosed within the same bony 
capsule and sharing the same fluid system. The hearing organ is located in the cochlea in the 
inner ear. The cochlea is spiral-shaped structure divided into three parallel fluid-filled 
compartments: scala vestibulo, scala media (the cochlear duct) and scala tympani (Figure 2). 
The two outer compartments, scala tympani and scala vestibuli are filled with a fluid called 
perilymph. Scala vestibuli and scala tympani are interconnected though a small opening at the 
apex of the cochlea called helicotrema allowing free movement of perilymph. The middle 
compartment, scala media, is filled with endolymph and is separated from scala vestibuli by 
Reissner’s membrane and from scala tympani by the basilar membrane. The hearing organ, 
the organ of Corti, rests on the basilar membrane. The organ of Corti consists of one row of 
inner hair cells (IHC) and three rows of outer hair cells (OHC) and different supporting cells. 
In one human cochlea, there are approximately 3,500 inner hair cells and 12,000 outer hair 
cells. The hair cells lie within a matrix of supporting cells on the basilar membrane. The 
stereocilia of the hair cells project into the overlaying tectorial membrane. Sound vibrations, 
entering into the cochlea through the oval window, creates pressure waves in the cochlear 
fluid that displace the basilar membrane, thus causing a relatively motion with respect to the 
tectorial membrane. The sensory hair cells detect the motion via their stereocilia. The hair 
cells are depolarized and following transmitter release and activation of the fibers of the spiral 
ganglion neurons, nerve impulses are generated.  
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1.1.2 Spiral ganglion neurons 
The spiral ganglion (SG), a collection of the cells bodies of the auditory neurons, is located in 
a bony canal of the cochlea called Rosenthal’s canal. The bipolar SG neurons extend 
processes towards the hair cells in the organ of Corti and auditory nuclei in the brain stem. 
There are two types of SG neurons, type I and type II, based on their different morphology, 
synaptic connection and function. Type I neurons, representing 90-95% of the neuronal 
population, are large and bipolar. They innervate the IHC in the organ of Corti. Their main 
function is to convey signaling from the IHC to the auditory brain stem. Type II neurons are 
small, bipolar or pseudomonopoler and represent 5-10% of the neuronal population. They 
innervate OHC in the organ of Corti. The exact function of type II neurons is not well 
established.  
 
Figure 2: Cross section of the cochlea. 
1.2 DEVELOPMENT OF SPIRAL GANGLION NEURONS 
The development of the embryonic inner ear arises from a thickening of the ectoderm in the 
head region of the vertebrate called the otic placode. The otic placode develops from the non-
neural ectoderm adjacent to the developing neural tube, which further invaginates to form the 
otocyst or otic vesicle. The pro-neurosensory domain of the otic vesicle gives rise to the 
neurons and sensory epithelial cells in the inner ear (Figure 3).  
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Figure 3: Development of auditory neurons. Modified from Gunewardene et al. 2012  
During development, the fate of the spiral ganglion neurons and sensory hair cells is specified 
by the proneural basic helix-loop-helix (bHLH) transcription factor Neurogenin 1 (NGN1) 
and the transcription factor ATOH1, also known as Math1 (Ma et al., 1998, Fritzsch et al., 
2010). Expression of NGN1 is necessary for the generation of the spiral ganglion neurons in 
the inner ear. In the mouse, deletion of NGN1 has been shown to result in a complete loss of 
spiral ganglion neurons (Ma et al., 1998, Ma et al., 2000). Specification of the neuroblasts 
takes place in otic vesicle by expression of NGN1, which in turn induces the expression of the 
neural differentiation bHLH transcription factor NEUROD1 (Ma et al., 1998). Loss of NGN1 
has been shown to result in the absence of NEUROD1 positive neuroblasts in the otic vesicles 
(Ma et al., 1998). Following the induction of NEUROD1, the neuroblasts start to delaminate 
from the otic vesicle and migrate out to from the cochleovestibular ganglion (CVG), which in 
turn further differentiates into spiral and vestibular ganglion neurons. NEUROD1 has also 
been shown to be of importance for spiral ganglion neuron differentiation and survival (Liu et 
al., 2000, Kim et al., 2001). Deletion of NEUROD1 results in the complete disappearance of 
CVG neurons after the delamination from the otic vesicles (Kim et al., 2001).  
The LIM-HD gene ISLET1 is restricted to cells in the neuronal lineage and is another 
important player in the development and differentiation of the proneurosenory domain. 
During sensory epithelium development, expression of ISLET1 is induced in parallel to 
induction of NGN1 and NEUROD1, but downregulated in the entire cochlear epithelium 
during sensory epithelium differentiation (Radde-Gallwitz et al., 2004). Thus, ISLET1 is an 
early marker for sensory epithelium and later marker for neural development.  
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Parallel to the otic development, the POU domain transcription factor BRN3A is expressed in 
facial-stato-acoustic ganglions prior to the differentiation of sensory neurons and otocyst 
innervation (Huang et al., 2001). BRN3A expression is important for proper growth and 
migration of neuroblasts in the innear ear and also involved in targeting innervation and axon 
guidance by the spiral and vestibular ganglion neurons (Huang et al., 2001). Loss of BRN3A 
results in a significant reduction and defective migration of spiral ganglion neurons 
(McEvilly et al., 1996). 
The zinc finger transcription factor GATA3 is another important transcription factor in spiral 
ganglion neurons. GATA3 is one of the earliest genes expressed in the spiral ganglion 
neuroblasts as well as in post-mitotic spiral ganglion neurons (Lawoko-Kerali et al., 2004, 
Karis et al., 2001, Duncan et al., 2011, Jones and Warchol, 2009). GATA3 is expressed 
throughout the early otic placode and the early otic vesicle, and with time limited to the future 
proneurosensory domain (Lillevali et al., 2006). Mouse studies have shown that GATA3 is co-
expressed with NEUROD1 throughout during initial proneurosensory domain but 
downregulated or even absent in the delaminating NEUROD1 positive neuroblast and the 
early CVG neurons (Lawoko-Kerali et al., 2004). In chicken, GATA3 expression is absent in 
all NEUROD1 positive neuroblasts in the otic vesicle (Jones and Warchol, 2009). In contrast, 
the post-mitotic spiral ganglion neurons in chicken and mouse express GATA3 (Jones and 
Warchol, 2009, Lawoko-Kerali et al., 2004). Conditional knockout mice have shown that 
GATA3 is important for the spiral ganglion survival and a proper axon projection in the inner 
ear at later stages of development (Luo et al., 2013).  
1.3 STRATEGIES FOR RESTORING SENSORINEURAL HEARING LOSS 
Degeneration of sensory hair cells and/or spiral ganglion neurons in the cochlea results in a 
sensorineural hearing loss. In mammals, neither of these cells can regenerate. Sensory hair 
cell regeneration has been a central target for therapeutic strategies for sensorineural hearing 
loss because of their crucial importance in conversion of sound stimuli to neural signals. An 
alternative approach is used by the cochlear implant, in which hair cell function is bypassed 
by directly stimulating spiral ganglion neurons. However, following loss of hair cells, 
secondary degeneration of spiral ganglions follows due to a lack of trophic support. 
Therefore, loss of spiral ganglion neurons challenges the clinical benefits of cochlear 
implants, and for this reason also spiral ganglion regeneration has been an important target 
for therapeutic strategies. Besides hair cells and spiral ganglion neurons, there are other 
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components in cochlea, which lack a regenerative capacity, e.g. the stria vascularis and spiral 
ligament at the later wall of cochlea.  
1.3.1 Cochlear implant 
A cochlear implant (CI) is an electronic device designed to stimulate SG neurons in the 
cochlea of patients with sensorineural hearing loss. The CI bypasses the affected hair cells 
and electrically stimulates the SG neurons. To date, more than 300,000 patients have received 
cochlear implants. This estimation represents small number of individuals who may 
potentially benefit from the implants. The CI has improved the quality of life of thousands of 
people since it was taken into clinical use. Based on the results reported by Djourno and 
Eyries, William House and John Doyle implanted the first CI in an adult in 1961. They 
inserted a gold wire electrode into the scala tympani in two deaf patients and electrical 
stimulation of this single-channel electrode provided some auditory sensation in these 
patients. In 1984, Graeme Clark developed a multichannel implant with bipolar stimuli. After 
that, the American Food and Drug Administration approved the use of CI in 1985. 
The cochlear implant device is composed of an external and an internal part. The external 
part includes the microphone, a cable and a sound processor. The microphone gathers sound 
from the environment, which is then analyzed by the sound processor and converted into 
electrical current. The internal part is surgically implanted under the skin behind the ear 
auricle and is comprised of a receiver/stimulator, a magnet, and a bundle of fine wire 
constituting the electrode array. The electrical current is delivered across the skin by radio 
waves to a receiver/stimulator, which convert them into electrical impulses. The current is 
transferred to the electrode array, which is implanted in the cochlea and activates the neurons 
connected to the cochlea resulting in the perception of sound. The whole concept of CI is to 
bypass the malfunctioning or absent hair cells and directly stimulate the remaining spiral 
ganglion neurons in the cochlea. 
1.3.2 Growth factor base survival 
Neurotrophic factors are secreted proteins, which play important roles in neuronal survival, 
neurite outgrowth and neuronal cell differentiation. Neurotrophins are synthesized by the 
targeted tissue or neurons at considerable distance from the neuronal cell body (Thoenen, 
1995). These factors are divided into different families; e.g., neurotrophins (brain derived 
neurotrophic factor, neurotrophin-3, nerve growth factor), growth factor family (e.g., 
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fibroblast growth factor), gila cells derived neurotrophic factor family and the neurokine 
family (e.g., ciliary neurotrophic factor). 
Since the discovery of neurotrophic factors there has been expectations of clinical 
applications for effective therapies for degenerative diseases. Neurotrophic factors are 
important in inner ear development and innervation during development (Fritzsch et al., 
1999). In addition they play important roles in survival and maintenance of spiral ganglion 
neurons in adulthood. Treatments with neurotrophic factors protect and prevent degeneration 
of cells in cochlea, triggered by drugs, noise or age. The two most commonly applied 
neurotrophic factors for treatment of the auditory system are the brain derived neurotrophic 
factor (BDNF) and neurotrophin-3 (NT-3). In situ hybridization studies have shown that 
BDNF and NT-3 are synthesized by sensory hair cells and that their targets, receptor tyrosine 
kinase B and C (TrkB and TrkC), are synthesized in the ganglion neurons during 
development (Pirvola et al., 1994, Pirvola et al., 1992, Schecterson and Bothwell, 1994, 
Wheeler et al., 1994, Ylikoski et al., 1993). Deletion of either BDNF, NT3, TrkB or TrkC 
results in loss of ganglion neurons in the cochlea (Minichiello et al., 1995, Fritzsch et al., 
1997, Farinas et al., 1994, Ernfors et al., 1995). This illustrates that the neurotrophins are 
essential for the survival of sensory neurons during development. In addition, BDNF and NT-
3 dramatically increase the survival of neurons in the adult rat spiral ganglion (SGNs). 
Degeneration of adult SGNs, normally seen after loss of hair cells in the cochlea, can be 
prevented by the exogenous neurotrophic factor NT-3 (Staecker et al., 1996, Ernfors et al., 
1996).  Infusion of NT-3 in ototoxically deafened animals resulted in significant survival of 
SGN after 2 (Miller et al., 1997), 4 (Gillespie et al., 2003), or 8 weeks of treatment (Staecker 
et al., 1996). Shepherd et al. showed that the infusion of intracochlear BDNF with patterned 
electrical stimulation resulted in significant increase in survival of SGN in deaf animals 
compared to treatment of BDNF treatment alone (Shepherd et al., 2005). A combined 
infusion of BDNF and CNTF resulted in not only an increased survival of spiral ganglion 
neurons in the deafened animals but also a significantly enhanced electrical responsiveness 
(Shinohara et al., 2002). Glia cell derived neurotrophic factor (GDNF) has been shown to 
provide protective effects on SGN survival and function (e.g. (Fransson et al., 2010, 
Maruyama et al., 2008)). A combination of GDNF with antioxidants significantly improved 
the electrically evoked auditory brain stem response (Maruyama et al., 2008). A positive 
intervention effect of intracochlear neurotrophic factor treatment has been shown for up to 6 
weeks post deafening (Yamagata et al., 2004).  
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A major challenge with neurotrophic treatment is the delivery method to the cochlea. 
Different methods have been used in different studies e.g., mini osmotic pumps, carrier based 
delivery, or encapsulated cells (Pettingill et al., 2011, Noushi et al., 2005, Havenith et al., 
2011, Agterberg et al., 2009, Shinohara et al., 2002). Although positive effects have been 
observed, these methods need further development. For example, commercially available 
mini-osmotic pumps have a limited life span, up to 4 weeks. Another alternative is to use an 
implantable pump that can be used for 8 months (Praetorius et al., 2001) but these pumps 
need refilling and with that an increased risk of infections in the inner ear. Another alternative 
is to deliver neurotrophic factors by local administration via the middle ear, e.g. using 
geloform or alginate (Noushi et al., 2005, Havenith et al., 2011). However, the effect of 
degradation of these carriers needs to be elucidated. An interesting approach could be to 
implant cells producing neurotrophic factors in order to provide intracochlear treatment for 
longer periods of time. For safety, these cells could be inserted encapsulated in a material 
allowing release into the cochlea. Using this technique with encapsulated BDNF 
overexpressing Schwann cells in animal experiments an improved survival of SGN has been 
shown (Pettingill et al., 2011). However, long term effect of these encapsulated cells need 
further research.  
1.3.3 Gene manipulation based regeneration  
Applying a gene therapy approach to induce upregulation or downregulation of specific genes 
is another option for inner ear treatment. For effective gene manipulation the gene in question 
must be delivered appropriately to the target cells. One method is to use viral vectors for the 
gene delivery. Till now, large numbers of vectors have been tested, from different families of 
viruses e.g., adenovirus, adeno-associated virus or lentivirus. Non-viral vectors, like plasmids 
or lipid-covered packages are also alternatives for gene delivery. Although they have 
advantages over viral vectors by reducing cell toxicity, these methods have shown low 
efficiency in terms of transduction of the gene and gene expression patterns. Electroporation 
has also been effective for gene delivery in cochlear explants (Zheng and Gao, 2000).  
The ATOH1 transcription factor was the first gene reported for specification of hair cells in 
the proneurosensory domain during development (for review (Fritzsch et al., 2010)). Targeted 
deletions of ATOH1 showed complete loss of hair cells in the mouse inner ear (Bermingham 
et al., 1999). Based on these findings, overexpression of ATOH1 gene was done in vitro by 
means of electroporation in the postnatal mammalian cochlea (Zheng and Gao, 2000) and in 
vivo by adenovirus vector transfer (Kawamoto et al., 2003, Izumikawa et al., 2005). Cochlear 
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explant cultures revealed induction of new hair cells in the epithelia ridge suggesting that 
epithelial cells in this region can transdifferentiate into hair cells (Zheng and Gao, 2000). 
Similarly, in vivo overexpression of ATOH1 resulted in the differentiation of new hair cells. 
Izumikawa et al. showed that new hair cells were connecting to the basal membrane 
suggesting a transdifferentiation from supporting cells (Izumikawa et al., 2005). In addition to 
new hair cells regeneration, this study also showed an improved hearing threshold in deaf 
mice.  
Down-regulation of cell cycle inhibitors by gene manipulation is another approach for new 
hair cells regeneration. Cell cycle regulators play important roles in the maintenance of the 
post mitotic cell state of supporting cells in the cochlea. During development, p27Kip1, a 
cyclin-depended kinase inhibitor, is upregulated in sensory epithelium and remains high in 
supporting cells until adulthood (Chen and Segil, 1999). Down-regulation of p27Kip1 
resulted in production of supporting cells as well as hair cells in the postnatal and adult organ 
of Corti (Lowenheim et al., 1999). A potential drawback with this approach is tumorigenesis 
due to uncontrollable cell proliferation in organ of Corti.  
Gene manipulation could be an effective approach for survival of spiral ganglion neurons in 
the cochlea. As it has been discussed earlier, neurotrophins are important for SGNs survival 
after loss of hair cells. Several gene therapy studies have reported introduction of 
neurotrophins to the mammalian inner ear (Rejali et al., 2007, Okano et al., 2006, Nakaizumi 
et al., 2004). Adenovirus based delivery of mouse BDNF into scala tympani of the guinea pig 
inner ear showed robust survival of SGNs compared to control (Nakaizumi et al., 2004). In 
another study, a protective effect of BDNF in SGNs survival was observed when cochlear 
implant electrodes were coated with BDNF secreting fibroblasts and inserted into scala 
tympani of deafened guinea pigs (Rejali et al., 2007). Wise et al studied prevention of spiral 
ganglion neuron degeneration as a result of aminoglycoside ototoxicity from adeno-
associated virus (Wise et al., 2011). Animals transfected with BDNF and NT3 showed a 
significant increase in survival of SGNs in the cochlea of 4 weeks old deafened animals.  
However, in prolonged observations (up to 8 weeks) the effect was diminished. The results 
illustrate the potential of this therapy but that the long-term benefits may be limited.  
1.3.4 Stem cell based cell replacement 
Cell replacement therapy has attracted great interest in regenerative medicine. The approach 
has also been proposed for the replacement or restoration of damaged hair cell and/or SGNs. 
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Stem cells are defined as having ability to self-renew and to differentiate into several cell 
types. Different types of stem cells have been used in differentiation and transplantation 
studies for hair cells and/or SGNs and some of them are discussed below. 
1.3.4.1 Auditory stem/progenitor cells 
Tissue specific stem cells are regarded as the best choice for cell therapy because of reduced 
risk for tumour development. Although the inner ear has limited ability to regenerate it is 
evident that stem cells are present. Several research groups have reported stem or progenitor 
cells in the animal cochlea, however their ability to regenerate is limited and the majority of 
these cells can differentiate only into a given phenotype such as hair cells (Zhai et al., 2005, 
Savary et al., 2007, Oshima et al., 2007, Malgrange et al., 2002) or SGNs (Rask-Andersen et 
al., 2005).  
Stem cells has been isolated in 9-11 weeks old human foetal cochlea and grown in culture in 
using medium containing bFGF, EGF, and IGF-1 (Chen et al., 2007, Chen et al., 2009). 
These stem cells express otic progenitor markers SOX2 and GATA3 as well as stem cell 
markers OCT-4, NANOG and REX-1. Human feotal audtitory stem cells can differentiate into 
hair cells when cultured in hair cell conditioned medium, and have been shown to express the 
hair cells markers ATOH1, BRN3C and MYO7A. When cultured in neural conditioned 
medium, they expressed SGNs markers NGN1, BRN3A, TUJ1 and NEUROFILAMENT 200 
(Chen et al., 2009). These human cells are promising candidates for future hair cell therapies, 
however, awaiting confirming results from transplantation in animals. 
1.3.4.2 Neural stem cells and neural crest stem cells 
Neural stem cells (NSC) have been reported to self-renew and differentiate into different 
types such as neurons, astrocytes and oligodendrocytes (Gage, 2000, Clarke et al., 2000).  
Previously, NSC have also been used for an inner ear cell therapy approach (Parker et al., 
2007, Hu et al., 2005b, Fu et al., 2009). Adult neural stem cells, transduced with neurogenin 
2, have been transplanted into normal and deafened animal cochlea (Hu et al., 2005b). This 
study showed poor survival of NSC in all groups even in a neurogenin-transduced group. 
Parker et al. reported interesting result when they transplanted an NSC cell line derived from 
immortalized male murine foetal cerebellum, from sound damaged animals (Parker et al., 
2007). NSC were found with characteristics of both cell of neural tissue and organ of Corti. 
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Neural crest cells arise just after the closure of neural tube between interface of neural tube 
and dorsal ectoderm. Neural crest cells undergo an epithelial to mesenchymal transition and 
delaminate from the neural tube and differentiate into different types of cells including 
peripheral sensory neurons.  Although it has been suggested that all cell types of the inner ear 
are derived from the otic placodal cells, it has been shown that neural crest cells also 
contribute as progenitors of glial Schwann cells of the cochleovestibular nerve and in small 
numbers in vestibular ganglions as well as melanocytes in the stria vascularis of cochlea 
(Hilding and Ginzberg, 1977).  
Recently, molecular comparisons of sensory neuron development from neural crest and otic 
placode have been made (Huisman and Rivolta, 2012). It was proposed that neural crest and 
otic placode share similar molecular events during the specification and differentiation of 
sensory neurons. Hence, both sources are important candidates for cell therapy approaches 
for the inner ear.    
1.4 PLURIPOTENT STEM CELLS 
Pluripotent stem cells (PSC) have the capacity to sustain an undifferentiated state, to self 
renew for long time as well differentiate (Thomson et al., 1998) (Figure 4).  Human diploid 
bonafide embryonic stem cells (hESC) and induced pluripotent stem (iPS) cells are classified 
as pluripotent.  
The first embryonic stem cell lines were developed from inner cell mass of a mouse embryo 
and reported in 1981 by Evans and Kaufman (Evans and Kaufman, 1981), This was followed 
by the report in 1998 of the first long term culture of human embryonic stem cells by 
Thomson (Thomson et al., 1998). Takahashi and Yamanaka 2006 reported the first mouse 
iPS cell line in 2006 (Takahashi and Yamanaka, 2006) and later also human iPS cell lines 
(Takahashi et al., 2007). 
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Figure 4: Differentiation of stem cell into different cell types. Modified with permission from © 2011 
Meregalli M, Farini A, Torrente Y. Published in Stem cells in Clinic and Research, Chapter 17 under CC BY-
NC-SA 3.0 license. Available from: http://dx.doi.org/10.5772/24013, http://dx.doi.org/10.5772/23660 
During the last decade, ES cells have been studied to replace hair cells and spiral ganglion 
neurons for inner ear regeneration. In one early study mouse ES cells were tagged with green 
fluorescent protein and delivered into the cochlea (Hildebrand et al., 2005). Survival of ES 
cells was observed at the site of transplantation as well as in the stria vascularis, endolymph 
fluid of scala media, and in the spiral ligament for up till nine weeks. However, cells failed to 
differentiate. In another study, transplanted cells showed extensive migration in cochlea and 
were observed not only in the cochlear nerve but also found present in the Rosenthal’s canal 
and the scala media (Sekiya et al., 2006). These cells showed tropism mostly toward the 
damaged cochlear nerve compared to undamaged nerve. However, neuronal differentiation 
was seen more in the undamaged nerve. In a separate study, ES cells were transplanted 
together with dorsal root ganglion tissue into the scala tympani and revealed migration 
towards the Rosenthal’s canal and close to the cochlear spiral ganglion neurons (Hu et al., 
2004a). Reyes et al. performed experiment with mouse ES cells conditionally expressing 
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neurogenin-1. After transplantation, neurogennin-1 was induced by doxycycline and 
continuous supplement of GDNF was provided for three weeks. This resulted in presence of 
transplanted cells in several areas of cochlea, with surviving cells with more neuronal like 
appearance and expressing the neuronal marker TUJ1 and the vesicular glutamatergic neuron 
marker vGLUT (Reyes et al., 2008). Although these studies have shown survival and 
differentiation of embryonic stem cells, the high risk of teratoma formation is evident. Due to 
this reason, it is important to differentiate ES cells into appropriate cell lineage before the cell 
implantation. In next section, different methods to induce neural differentiation from ES cells 
are discussed. 
1.4.1 Methods to induce neural differentiation in pluripotent stem cells 
Due to a very limited capacity of regeneration of inner ear hair cells and/or spiral ganglion 
neurons, treatment of sensorineural hearing leoss is one of the major challenges in field of 
medicine. Clinically, cochlear implants have been used to treat sensorinerual hearing loss for 
about three decades. As the spiral ganglion neurons are the target for the electrical stimulation 
by the CI, several studies have been conducted to improve survival of SGN cells, e.g. using 
different growth factors. It has also been attempted to replace SGN cells by exogenous cell 
types transplanted into the cochlea. However, the outcome has so far not been convincing, 
primarily due to a low survival rate of these exogenous cells. However, the development of 
iPS cells may make it possible to treat with patient their own specific cell types to reduce the 
risk of an immune and subsequent tissue rejection It is important to differentiate pluripotent 
stem cells into appropriate candidate of neural progenitors that can function like SGN. 
Different methods have been used to induce neural differentiation from pluripotent stem cells. 
1.4.1.1 Embryoid body (EB) formation and monolayer cultures 
The formation of embryoid body form ES cell is a common method for producing different 
cell lineages for further applications. The simple method of EB formation is achieved by 
culturing ES aggregated in suspension without any growth factors on non-adherent dishes. 
This EB formation method results in multilayer 3D structures containing cells from all three 
germ layers: ectoderm, endoderm and mesoderm (Schuldiner et al., 2001).  Previously, many 
groups have used this method to induce neural differentiation from ES cells (Zhou et al., 
2008, Schuldiner et al., 2001, Reubinoff et al., 2000, Mohr et al., 2010). This is a 
straightforward method but have some drawbacks, including long-term cell culture, 
development of cyst and required high concentration of extrinsic factors to penetrate deep 
inside the EBs (Wichterle et al., 2002, Schuldiner et al., 2001, Carpenter et al., 2001, Bain et 
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al., 1995). Embryoid bodies can be formed by the hanging drop method (Cerdan et al., 2007), 
floating small aggregates of ES cells (Schuldiner et al., 2001), and multiwall plates (Koike et 
al., 2005, Mohr et al., 2010). Another method of neural differentiation is achieved by 
prolonging culturing of ES cells as monolayer without splitting for 3 to 4 weeks (Reubinoff et 
al., 2000, Shin et al., 2006). This method permitted ES cell to grow in two dimension and ES 
colonies pile up to each other and start to differentiate. A wide range of cell types have been 
observed in these flat cultures, including ectodermal neuronal cells, mesodermal muscle and 
endodermal organ tissue types (Reubinoff et al., 2000).  These two methods can be combined 
to induce neuronal differentiation (Zhang et al., 2001, Ali et al., 2014). First EB can be 
formed and allowed to attach on coated plates to form a monolayer culture.  
1.4.1.2 Stromal-derived inducing activity (SIDA) 
Co-culture techniques with stromal cells have provided efficient method to promote neuronal 
differentiation. The first reported methods used PA6 stromal cell line (Kawasaki et al., 2000), 
isolated from skull bone marrow (Kodama et al., 1986), to induce neural differentiation from 
mouse ES cells. Another cell line MS5 from stromal feeder cells has also been successfully 
used to promote neuronal differentiation of mouse and human ES cells (Perrier et al., 2004, 
Barberi et al., 2003). A variety of neuronal phenotypes have been generated by using SIDA 
methods e.g., midbrain dopaminergic neurons (Zeng et al., 2004), peripheral sensory neurons 
(Brokhman et al., 2008), neural crest cells (Pomp et al., 2005, Lee et al., 2007a) and motor 
neurons (Lee et al., 2007b). The exact mechanism of SIDA on inducing neuronal 
differentiation is unknown. Several studies have reported that fixed PA6 cells also induced 
neuronal differentiation when co-cultured with ES cells, indicating that differentiation was 
induced by interaction with membrane bound molecules (Vazin et al., 2008, Kawasaki et al., 
2000). However, others have showed condition medium obtained from PA6 cells was enough 
to induce neuronal differentiation, suggesting the involvement of secreted factors (Hayashi et 
al., 2008, Vazin et al., 2008, Schwartz et al., 2005). This method is also an efficient method 
for neuronal differentiation but it may introduce unknown factors thus limiting it for clinical 
use.  
1.4.1.3 Growth factors and media supplements 
In the beginning, neural differentiation was considered as a default pathway, suggested by 
different animal studies (reviewed in (Stern, 2006)). Different growth factors have shown to 
be important for neuronal differentiation such as bFGF, Noggin, retinoic acid. Ying et al. 
cultured ES cells as a monolayer in serum free condition and showed that bFGF is crucial for 
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proper neuronal differentiation (Ying et al., 2003). Interestingly, mouse ES cells were 
differentiated into primitive neural stem cells fate in the absence of exogenous or paracrine 
bFGF but under this conditions, cells were unable to survive and proliferate further without 
bFGF (Smukler et al., 2006). These studies show the dispensable role of bFGF during initial 
steps but that it later is essential for cell survival, proliferation and differentiation. bFGF is 
also used to isolate and maintain neural precursors derived from ES cells (Elkabetz et al., 
2008, Dhara et al., 2008) as well as to generate neural differentiation (Benzing et al., 2006, 
Axell et al., 2009). Noggin, a BMP inhibitor, is another protein that has been used by 
different groups to induce neural differentiation of ES cells grown adherently (Pera et al., 
2004, Gerrard et al., 2005, Baharvand et al., 2007), co-cultured with MS5 stromal cells 
(Elkabetz et al., 2008, Lee et al., 2007b), or as EB in suspension (Itsykson et al., 2005). 
Besides bFGF and noggin, retinoic acid is also most commonly used factor to induce neural 
differentiation. Different concentration of retinoic acid results in wide range of neuronal fate 
(Baharvand et al., 2007, Carpenter et al., 2001, Zhang et al., 2001, Erceg et al., 2008) at 
various stages of differentiation (Carpenter et al., 2001, Schuldiner et al., 2001). 
Media supplements have also impact on neural differentiation when differentiation is done on 
serum free conditions. Two most common supplements used as media supplements are N2 
and B27. An N2 supplement is used in most neuronal differentiation protocol and contains 
five components, transferrin, insulin, putrescine, progesterone and selenite. These 
components are shown to induce neural differentiation (Savaskan et al., 2003, Cai et al., 
2002, Aizenman and de Vellis, 1987). On the other hand, B27 supplement contains the same 
five components as N2 and some additional components, e.g. vitamins, hormones etc., and 
used in protocols for neuronal differentiation of ES cells (Gerrard et al., 2005, Itsykson et al., 
2005, Nat et al., 2007). The exact composition of B27 has not been disclosed.  
1.4.1.4 Small molecules 
Chemical approaches have been particularly useful for direct conversion of stem cell into any 
specific cell lineages and maintenance of stem cell pluripotency (detail reviewed in (Li et al., 
2013, Xu et al., 2013)). Small molecules are very useful in differentiation of stem cells. They 
have a number of advantages, e.g. high target specificity, ease of use, and the effect can be 
tuned by varying concentration and combinations and can modulate their effect at any time. 
Small molecules are widely using in neural induction protocol in recent times. Studies have 
shown that the SB431542 molecule, inhibitor of Activin/Nodal signaling pathway by 
blocking phosphorylation of ALK4, 5, and 7 receptors, can induce neuronal differentiation in 
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EB based or adherent based differentiation protocol (Patani et al., 2009, Smith et al., 2008). 
Besides SB431542, some other small molecules such as LND193189 (inhibitor of type1 
receptor ALK2/3), CHIR99021 (GSK3β inhibitor), dorsomorphin (inhibitor of BMP type 1 
receptors ALK2/3/6) have been shown to promote neuronal induction either alone or in 
combination with other small molecules (Morizane et al., 2011, Li et al., 2011, Chambers et 
al., 2012). Chambers et al. showed that the combination of SB431542 and noggin protein was 
sufficient to enhance neural induction from ES cells (Chambers et al., 2009). Recently, they 
also showed that pluripotent stem cells can be accelerated developmental timing and 
converted into nociceptors neurons (Chambers et al., 2012). In this study, SB431542 and 
LND193189 were first used to induce neuronal differentiation and then three small 
molecules, SU5402 (inhibitor of FGF, VEGF and PDGF signaling), CHIR99021 and DAPT 
(γ-secretase inhibitor), were added. Combining these small molecules induces more than 75% 
of neuron in 10 days of time. 
1.5 INDUCTION OF SENSORY NEURONS FROM PLURIPOTENT STEM CELLS 
Neural crest derived sensory neurons have been generated by culturing hES with PA6 stromal 
cell lines (Pomp et al., 2008, Jiang et al., 2009, Pomp et al., 2005, Brokhman et al., 2008). 
When human ES cells were cultured on a PA6 cell line, differentiation of sensory neurons 
was seen but yield was very low (less then 1%) (Pomp et al., 2005). Later, they combined 
two techniques; first they generated neurospheres by treating with noggin in suspension and 
then these neurospheres were dissociated and cultured on a PA6 cell line. This methods 
produced a 10-fold increase of sensory neurons (Brokhman et al., 2008). Further 
improvement was achieved when human ES cell were cultured with PA6 cell line for two 
weeks. Colonies were then detached from PA6 cultures and cultured in petri dishes to form 
neurospheres. After forming neurospheres, dissociated cells were again cultured on fresh PA6 
cells to differentiate into sensory neurons. This method not only increased the yield of 
sensory neurons (more the 25%) but also the purity of sensory neurons (Pomp et al., 2008). 
Jiang et al. showed that the efficiency of neural crest stem cells (NCSC) differentiation from 
human ES cell can be increased by combining SIDA culture and FACS based enrichment 
(Jiang et al., 2009). In their study, they cultured human ES cells with PA6 cells for 1 week 
and identified that half of colonies were positive for p75 receptor protein and vast majority of 
colonies were also positive for HNK1 (a general NCSC marker). Later they sorted out p75 
positive cells by FACS and showed not only differentiation into sensory neuron but also 
showed neural crest derivatives in developing chick embryo in vivo. Recently, human ES 
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cells were differentiated into NCSC by growing human ES in suspension culture to form EBs 
(Liu et al., 2012) . EBs were cultured in medium containing 50% neurobasal medium with 
b27 and bFGF and 50% PA6 conditioned medium for 10 days and then cultured on geltrex-
coated dishes for 4 days. NCSC were sorted with FACS by p75 marker. Differentiation of 
NCSC showed 25% sensory neurons in the cultures. Small molecules have shown that ES 
cells can be induced to particular lineages. Different small molecules have been shown to 
induce neural differentiation (discussed earlier). Recently, Denham et al. showed that 
inhibition of glycogen synthase kinase 3ß and Activin/Nodal pathways by small molecules 
differentiated human ES into preneuroepithelial progenitors. Exposure to bFGF on these cells 
directed them towards NCSC and they further differentiated into sensory neurons (Denham et 
al., 2015). Sensory neural fate from stem cells has been compared from three different in 
vitro treatments (Nayagam and Minter, 2012). Mouse stem cells were first differentiated in 
suspension culture to form EBs for days and then treated with retinoic acid to induce neural 
differentiation for 4 days. These EBs were then cultured in three different media; 
neurotrophin medium (BDNF and NT3), conditioned medium (from sensory explant 
cultures) and BMP4 containing medium. This study showed that BMP4 showed highest 
number of PERIPHERIN and TrkB positive cells (9 to 10%) compared to other treatment.  
Human embryonic stem cell has been differentiated into auditory like sensory neurons. 
Human ES cell were cultured as suspension to formed EBs in N2 medium and then treated 
with BMP4 (Shi et al., 2007). This treatment induced ES cell into sensory like neurons, 
expressing BRN3A, PERIPHERIN, NGN1, GATA3 and TUJ1. Animal studies from these 
cells also showed the survival and engraftment in animal cochlea. In recent study, otic neural 
progenitor cells were derived from human ES and iPS cell (Chen et al., 2012). Cell were 
cultured as monolayer in the presence of FGF3 and FGF10 and further cultured in bFGF and 
sonic hedgehog, followed by NT-3 and BDNF supplementation. Cells were expressing otic 
marker PAX2, PAX8 as well as SOX2 and upon differentiation neurons expressed BRN3A and 
TUJ1. Transplantation studies also showed the survival of these cells in the cochlea, and that 
the implanted animals also gained auditory brain response. Gunewardene et al. also showed 
the stepwise differentiation of auditory like neurons from human ES and iPS cells 
(Gunewardene et al., 2014). Monolayer culture of stem cells in bFGF, noggin, N2 and B27 
for 14 days to induced PAX2 and PAX7 positive cells. Colonies then cultured as suspension in 
bFGF and EGF and then attached on day 18 on human fibroblast and cultured for 35 days. 
During this differentiation step the expression of key makers for auditory development on 
cells was analyzed, e.g., NEUROD1, BRN3A, ISLET1, GATA3, vGLUT1, TUJ1 and 
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NEUROFILAMENT. It has been also shown that sensory neurons derive from this protocol 
exhibited electrophysiological properties (Needham et al., 2014). Recently, Dincer et al. 
showed that combination of SB431542 and noggin at different time point could induce 
placodal cell types (Dincer et al., 2013). Removal of noggin after three days and culturing 
human ES in SB an additional 11 days, significantly induced the expression of markers for 
developing placodal. They also showed that these placodal cells differentiated into sensory 
neural types expressing BRN3A, ISL1, GLUTAMATE and PERIPHERIN.  
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2 AIMS 
The overall aim of the thesis was to establish and analyze differentiation of auditory like 
sensory neurons from human embryonic stem cell for inner ear cell therapy approach. 
Specific aims 
• To design and evaluate cell culture conditions for the generation of sensory neurons 
• To identify and modulate genes or signaling pathways by which in vitro 
differentiation towards sensory neurons can be enforced 
• To investigate gene expression patterns during the course of differentaition towards 
sensory neurons from PSC cells  
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3 MATERIALS AND METHODS 
3.1 CELL CULTURES 
3.1.1 Human foreskin fibroblasts cells (Paper I) 
Commercially available human foreskin fibroblast cell (CRL-2429 from ATCC) were 
cultured in Isocov’s Modified Dulbecco’s Medium with 10% fetal bovine serum and 1% 
penicillin/streptomycin (all reagents from Invitrogen) and incubated at 37°C, 6.8% CO2 and 
95% humidity. Cells were mitotically inactivated by treatment with mitomycin C (10µg/ml) 
for 3 hours. After 3 hours, cells were plated at density of 2x104 cells/cm2 on 6 well plates 
(BD Falcon). Fibroblasts were allowed to attach for 2-5 days prior to used as feeder layer. 
3.1.2 Human embryonic stem cells (Paper I and II) 
The human embryonic stem cell line HS181 were used to performed all the experiments. 
HS181 were cultured (Paper I) in knock-Out Dulbecco’s Modified Eagle Meduim (KO-
DMEM) containing 20% Knock-Out Serum Replacement (KO-SR), 2 mM L-glutamine, 1% 
nonessential amino acids, 0.1mM ß-mecaptoethanol and 4ng/ml basic fibroblast growth 
factor (bFGF) (all reagents from Invitrogen). Cells were passaged every 3-5 days depending 
on the seeding by using Dispase (10mg/ml) (Invitrogen) for 5-7 min at 37°C with mild 
mechanical separation. Cell were then washed twice, plated on feeder layer (at ration of 1:3 to 
1:4 well) and incubated at 37°C, 6.8% CO2 and 95% humidity with daily change of medium.  
For Paper II, HS181 were cultured as feeder free system. HS181 cell were cultured in 
Essential 8 medium (DMEM/F-12 (HAM) 1:1) and Essential 8 supplement (50X) (Life 
technologies). Prior to splitting, 6 well plates were coated with human recombinant 
vitronectin (0.5µg/cm2) (Life technologies) for 1 hour at room temperature. Confluent HS181 
cells were washed twice with Dulbecco’s phosphate buffer saline (DPBS) without calcium 
and magnesium and incubated with 0.5mM EDTA in DPBS in each well for 4-5 minutes at 
37°C. EDTA was removed and pre warmed medium was added in each well and gently 
pipetting colonies up by 5 ml pipette and transferred to 6 well plated pre-coated with 
vitronectin at ration of 1:4 to 1:6 well. Plates were gently tapped to disperse cell in each well 
and incubated at 37°C, 6.8% CO2 and 95% humidity with daily change of medium. 
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3.1.3 Human neuroepithelial stem cells (Paper III) 
Long-term neuroepithelial stem cell lines (AF22 and C1GFP) were derived from iPS cells 
and were cultured in DMEM/F-12 with l-glutamine, N2 (1:100), B27 (1:1000), 
Penicillin/Streptomycin (1:100), bFGF (10ng/ml) and hrEGF (10ng/ml) (Life technologies). 
Prior to splitting, flasks were coated with 0.1mg/ml polyornithine (Sigma) for 30-60 min at 
37°C, washed twice with DPBS and immediately added 2µg/ml laminin (Sigma) and 
incubated for 4 hours at 37°C. Flasks were incubated with TrypLE express (Life 
technologies) for 3-4 min at 37°C and then detached cells by gentle tapping and spin with 
medium. Split ration was 1:3 if cells were 100% confluent otherwise 1:2 to maintain high cell 
density. Flasks were split every 2-3 days. 
3.2 EMBRYOID BODIES FORMATION AND NEURAL DIFFERENTIATION 
(PAPER I AND II) 
In paper I, confluent hES cells were treated with Dispase as described above and hES 
colonies were manually picked and detached from feeder layers. These colonies were 
transferred to 60-mm petri dishes (BD Falcon) in embryoid medium (Knock-Out Dulbecco’s 
Modified Eagle Medium (KO-DMEM) containing 20% Knock-Out Serum Replacement 
(KO-SR), 2 mM l-glutamine, 1% nonessential amino acids and 0.1mM ß-mecaptoethanol (all 
reagents from Invitrogen). Next day, EBs were transferred to new petri dish to remove 
unattached feeder cells. Embryoid bodies were cultured in suspension for 4 days with daily 
change of complete medium. After 4 days, embryoid bodies were cultured in NIM medium 
supplemented with bFGF (20ng/ml) for 2 days. The composition of NIM medium is KO-
DMEM, 2 mM l-glutamine, 1% nonessential amino acids and N2 supplements (1:100). 
Embryoid bodies after 6-days in suspension cultured, were cultured as adherent on 4-well 
plates (Nuclon). 4-well plates were pre-coated with 20µg/ml laminin (Sigma) for over night 
at 37°C (Paper I). EBs were transferred 4-well plates (4-5 EBs per well) and cultured in NIM 
medium supplemented with bFGF (20ng/ml) for 4, 7, 11 days. Cells were treated with mild 
Dispase (0.5 mg/ml) for 15-20 minutes to dissociate neural rosettes from surrounding non-
neural structures. The dissociated neural rosettes were transferred to 6-well plates to adhered 
to non neural cells for 1 hour while floating clumps of neural cells were plated again on 
laminin coated 4-well plates in NIM medium for 1 week or 3 weeks. Half of the medium was 
replaced every second day.  
In paper II, AggreWell plates (Stem Cells Technologies) were used to form EBs. Confluent 
hES cells were treated with Accutase (Sigma) for 5-6 min at 37°C. cells were detached and 
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dissociated cells with gentle pipetting the cell suspension for 2-3 times. Cell were transferred 
to 15 ml tube and washed well with DMEM/F-12 medium and transferred to same 15 ml 
tube. Cells were spin down and resuspended in TeSR E6 medium (DMEM/F-12 with TeSR-
E6 20X supplements from Stem Cells Technologies) with 10µm Rho-Kinase inhibitor (Y-
27632) (Calbiochem). Ten thousand cells per microwell were added to each well of 
AggreWell plate in TeSR-E6 medium with Rho-Kinase inhibitor and cultured for 24 hours at 
37°C, 6.8% CO2 and 95% humidity. Next day, EBs were dislodged from AggreWell plate by 
gentle pipetting and transferred to petri dish with TeSR-E6 medium. EBs were transferred to 
35-mm petri dishes (BD Falcon) and cultured for 6 days as suspension culture in TeSR-E6 
medium supplement with either TGFß/Activin/Nodal pathway inhibitor SB431542 at 
concentration of 20µm or IGF-1 (Life Technologies) at final concentration of 10ng/ml or a 
combination of these two supplements. Control cultures were treated with 0.1% DMSO 
(Sigma) and all the medium was changed daily. After 6 days treatment, EBs were transferred 
to 4-well plates (Nuclon), pre-coated with 0.1mg/ml polyornithine (Sigma) for 30-60 min at 
37°C, washed twice with DPBS and immediately added 20µg/ml laminin (Sigma) and 
incubated for over night at 37°C in DMEM/F-12 medium with l-glutamine, N2 supplements 
(1:100), nonessential amino acids (1%), penicillin/streptomycin (1:100) and bFGF (20ng/ml 
(all reagents from Life technologies) for 7 days with complete change of medium every 
second day. In the next step, cell were further cultured for 7 more days in DMEM/F-12 
medium with l-glutamine, N2 supplements (1:100), B27 (1:100) nonessential amino acids 
(1%), penicillin/streptomycin (1:100) and BDNF/NT-3 at concentration of 10ng/ml. Half 
medium was changed every second day. 
3.3 NEURAL DIFFERENTIATION (PAPER III) 
3.3.1 Dose response experiments 
Dose response experiments were performed with Isoxazole 9 (ISX9) molecule (Torcis). Prior 
to experiment, cover slips were coated with 0.1mg/ml polyornithine (Sigma) for 30-60 min at 
37°C, washed twice with DPBS and immediately added 2µg/ml laminin (Sigma) and 
incubated over night at 37°C. Cell were plated at density of 50,000 cell/ cm2 in NES 
differentiation medium (1:1 ratio of DMEM/F-12 and Neurobasal medium, N2 (1:100), B27 
(1:100)) for 2 days to attached on cover slip. After 2 days, NES differentiation medium were 
added with ISX9 at concentration of 5, 10, 20 or 40µm for 4 days. 
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3.3.2 Differentiation experiments 
For differentiation experiments, cells were plated on polyornithine/laminin-coated plates for 2 
days in NES differentiation medium as described above. ISX9 and SB431542 were dissolved 
in DMSO and Metformin (Tocris) was dissolved in distilled water. After 2 days, cells were 
treated with small molecules ISX9 (20µm; identified by dose response experiments), 
SB431542 (10µm) and Metformin (500µm) in NES differentiation medium for 4 days with 
daily changed for medium. In following step, cells were cultured in NES differentiation 
medium with BDNF (10ng/ml) and NT-3 (10ng/ml) for another 7 days and half medium was 
changed every second day. 
3.4 EXPRESSION ANALYSIS 
3.4.1 RNA extraction and reverse transcription (RT) PCR (Paper II and III) 
Total RNA was extracted by using Trizole reagent (Life Technologies) according to 
manufacturer’s instructions. RNA was dissolved in 20µl water (Sigma, Molecular biology 
grade). The concentration of RNA was measured by NanoDrop1000 spectrophotometer 
(Thermo Scientific). One microgram RNA, pre-treated with RNase free DNase according to 
manufacturer’s protocol (Invitrogen), was used for RT-PCR. High capacity RNA to DNA kit 
was use for RT-PCR according to supplier’s recommendation (Life Technologies). 
3.4.2 Polymerase chain reaction (PCR) (Paper II) 
Polymerase chain reaction was performed in 25µl reaction mix by using following 
components: 1µl of cDNA (50ng), 0.5ml o each primer (0.4µM each), 0.5µl MgCl2 (1mM), 
0.5ml dNTPs mix, (0.2mM each), 2.5µl 10X PCR mix (1X) 0.2µl Platinum Taq DNA 
polymerase (4 units) and DNas/RNase free water (all reagents from Invitrogen). The thermal 
cycling parameters for PCR reaction were done as follow: initial denaturation at 95°C for 10 
min followed by denaturation at 94°C for 50 sec, annealing at 55°C (for OCT-4 and GAPDH) 
and 56°C (for NODAL) for 50 sec, extension at 72°C for 50 sec in 30 cycles and final 
extension at 72°C for 5 min. The primer sequences were as follow: GAPDH, GCT CAG 
ACA CCA TGG GGA AGG T/GTG GTG CAG GAG GCA TTG CTG A (F/R, size 470bp); 
OCT-4, AGG ATC ACC CTG GGA TAT ACA CA/AAG CTA AGC TGC AGA GCC TCA 
(F/R, size 113bp); NODAL, CAT GAA AGC TAT AGG TGA CTT CAT/TGT AAA TGA 
AGG GCT CAG TGG A (F/R, size 250bp). 
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3.4.3 Real time PCR (Paper II and III) 
Gene expression was quantified in Applied Biosystems 7500 real time PCR system using 
SYBR Green master mix (Applied Biosystems). Primers were purchased from commercially 
available KiCqStart from Sigma for following genes; GATA3, BRN3A, NEUROD1 and 18S 
(for Paper II and III), NESTIN and NGN1 (Paper II only) and PERIPHERIN (Paper III only). 
Amplification was carried out in 96 well optical plates using 4µl diluted cDNA (20ng), 10µl 
master mix, 0.5µl of each primer and 5µl of water. All reactions were performed according to 
standard protocol of 40 cycles of denaturation-annealing. The ribosomal mRNA 18S was 
used to normalized and relative expression levels were reported as 2-∆∆CT for fold changes. All 
reactions were performed in triplicate and repeated three times from with RNA samples from 
separate cell cultures.  
3.4.4 Immunocytochemistry 
Cells were fixed in 4% paraformaldehyde solution for 15-20 min at room temperature. After 
fixing, cells were washed twice with DPBS and permeabilized with TTPBS (0.5% triton X-
100 + 1% Tween 20 in PBS) in Paper II and III. No permeabilization was done in Paper I. 
Cells were incubated with blocking buffer (10% fetal bovine serum + 0.1% Tween 20 in 
PBS) for 30 min in Paper I and (3% bovine serum albumin in TTPBS) for 1 hour in Paper II 
and III at room temperature. Primary antibodies were diluted in respective blocking buffer 
and incubated at 4°C for overnight. Next day cells were washed three times with PBS (Paper 
I) or TTPBS (Paper II and III) for 5 min each. Secondary antibodies were diluted in PBS and 
cells were incubated for 2 hours at room temperature. Cell were again washed three times 
with PBS or TTPBS for 5 min each and mounted with Vectashield DAPI (Vector labs Inc) 
(Paper I) or conterstained with DAPI. 
Following primary antibodies were as followed: Ki67 (Abcam, 1:200), CLEAVED CASPASE 
3 (Cell Signaling, 1:200), ACTIVE CASPASE 3 (BD Pharmingen, 1:200), NESTIN (Abcam, 
1:500), NESTIN (Chemicon, 1:200), TUJ1 (Covance, 1:500 and 1:1000), TUJ1 (Millipore, 
1:700), ISLET 1 (DSHB, 1:50), BRN3A (Millipore, 1:200), PERIPHERIN (Chemicon, 1:200), 
TrkB (Santa Cruz, 1:200) and TrkC (Santa Cruz, 1:200). Respective secondary antibodies 
were as followed: goat anti mouse and rabbit Alexa 488 or 594 (Invitrogen, 1:200), donkey 
anti mouse cy3 (Jackson Immunoresearch, 1:400), donkey anti chicken cy5 (Jackson 
Immunoresearch, 1:400), donkey anti rabbit cy5 (Jackson Immunoresearch, 1:400). 
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In paper I, all fluorescent microscopic images were captured using Axiovision (Carl Zeiss). In 
paper II and III, an LSM 700 confocal microscope (Carl Zeiss) was used to capture images.  
3.5 STATISTICS 
GraphPad Prism statistical software was used to perform all the analysis. Statistical 
differences were measured by One-Way ANOVA (Paper I-III) and unpaired t-Test was done 
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4 RESULTS AND DISCUSSION 
4.1 PAPER I 
Differentiation of human embryonic stem cells towards a sensory neural phenotype  
Human embryonic stem cells (hESC) have been shown to have the potential to differentiate 
into specific cells types, leading to great attention in regenerative medicine for treatment of 
neurodegenerative diseases. In this study, we differentiated hESC into sensory neurons 
phenotypes from different time stages of in vitro generated neural rosettes. With this 
approach, we could expect the bulk of cells to be differentiated neurons but also some level of 
possible contamination with heterogeneous cells populations derived from primitive neural 
ectoderm during early stages of differentiation. 
We first generated embryonic bodies (EBs) from the hESC line HS181. After transfer of EBs 
to neural induction medium, neural rosettes started to appear from day 4. These rosette 
structures persisted until our last tested stage day 11. Neural rosettes are elongated columnar 
cells, which has previously been resembled to primitive neural ectoderm (Wilson and Stice, 
2006), and express many of the protein presents in neuroepithelial cells of the neural tube 
(Wilson and Stice, 2006, Curchoe et al., 2012). The neural rosettes were cultured for 4, 7 and 
11 days in the presence of bFGF (the cultures were denoted NS4, NS7 and NS11, 
respectively). Studies have shown that bFGF is important in the differentiation of neural 
progenitors from hESC (Zhang et al., 2001, Stern, 2006). Immunostaining showed that the 
rosettes were positive for NESTIN and TUJ1 at all stages where NS11 cultured showed more 
mature neuronal population compared to NS4 and NS11. These results, in line with previous 
studies, suggest the presence of neural cells (Erceg et al., 2009, Zhang et al., 2001). We then 
further investigated the proliferation (by Ki67) and apoptosis (by CLEAVED CASPASE 3) in 
the NS4, NS7 and NS11 cultures. Proliferation capacity was similar in all the cultures after 
one week (NS4; 33.6%, NS7; 32.4 and NS11; 30.5). However, apoptosis was significantly 
higher in NS11 cultures (15.3%) compared to NS4 (10.2%) and NS7 (11.4%). Presence of 
more mature neuronal population in NS11, which undergo degeneration could explain the 
higher number of apoptotic cells. 
Neural rosettes, from NS4, NS7 and NS11, were re-plated and differentiated for a one- or 
three-week period of culture. After one week, we observed high number of cells positive for 
NESTIN in all cultures (97%, 92% and 88%, respectively). Three-week cultures showed a 
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significant decrease in NESTIN positive cells in NS4 (48%) and NS7 (49%) cultures but not 
in NS11 (89%) cultures. TUJ1 staining showed higher number of positive cells in cultures 
after one week in NS4 (84%) and NS11 (79%) compared to three weeks in NS4 (40%) and 
NS11 (57%). On the other hand, NS7 cultured showed similar number of cells positive for 
TUJ1 after one week (72%) and three weeks (69%).  
We next investigated that neural rosettes from different stages has effect on differentiation 
towards sensory neural phenotypes. For this we used three markers, PERIPHERIN, TrkB and 
TrkC. PERIPHERIN is an intermediate filament protein expressed in axons of peripheral 
sensory neurons in combination with TUJ1 (Troy et al., 1990, Schimmang et al., 1995, 
Postigo et al., 2002), but can also be detected in some sympathetic ganglion and motor 
neurons (Escurat et al., 1990). PERIPHERIN/TUJ1 exhibited a similar expression range (9-
12%) in NS4 and NS7 cultures at the one- or three-weeks time points, but the NS11 cultures 
showed less than 1% PERIPHERIN/TUJ1 positive cells at both time points.  
Trk receptors (TrkB and TrkC) are important for neuronal survival of sensory neurons of 
spiral ganglion and dorsal root ganglion neurons (Ernfors et al., 1993, Schimmang et al., 
1995). TrkB/ TUJ1 staining did not revile any differences at the three different time points 
(NS4, NS7 and NS11) after one or three weeks. However, TrkC/TUJ1 staining in NS4 
cultures showed an increased in the number of positive cells (17%) at three weeks compared 
to one-week cultures (<1%) whereas the NS11 cultures did not show much difference 
between one week (<1%) and three weeks (3%). NS7 cultures showed higher number of 
TrkC/TUJ1 positive cells  (20%) in both, one week and three weeks cultures.  
Previously, it has been shown that the neurogenic potential of rosettes cultures decreases with 
time and that GFAP positive glia cells appear more frequently (Abranches et al., 2009). This 
indicated a switch from neurogenic to gliogenic identity of the progenitor cells. Although we 
did not test markers for other progenitor types, our data for NS11 also suggests that NS11 
rosettes displayed a reduced potential to differentiate into sensory neurons compared to the 
NS4 and NS7 cultures. However, NS4 and NS7 showed similar or higher number of 
PERIPHERIN positive cells compared to published protocols (Pomp et al., 2005, Brokhman 
et al., 2008) but our result did not match the results of the recently developed protocol 
showing 40% to 70% of PERIPHERIN positive neurons (Lee et al., 2010, Chambers et al., 
2012).  
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In conclusion, we could show that the NS7+1week protocol was the most favorable protocol 
in comparison to other tested protocol, based on PERIPHERIN and TrkC expression. This 
protocol showed induction of upto11% of PERIPHERIN and 20% of TrkC positive cells.   
4.2 PAPER II 
The TGFß/Activin/Nodal pathway inhibitor SB431542 is a potent inducer of sensory 
neural markers when applied to neural differentiation from HS181 embryonic stem cells 
The development of a stem cell based cell therapy will require an efficacious differentiation 
of stem cells into the appropriate neurosensory lineages. Signaling pathways have major 
impact on the maintenance of pluripotency and differentiation into particular lineages. In this 
study we showed that blocking of Activin/Nodal pathway by small molecule, exit hES cells 
from pluripotency and differentiate them towards neural and sensory neural phenotypes. With 
this approach, we directed the HS181 cells to mainly differentiate into neuroectodermal 
lineage and blocked/reduced the mesoderm and endoderm differentiation. We could assume 
that this approach could also generate other types of neurons as well in the cultures.  
Small molecule, SB431542 (SB) induced a downregulation of the pluripotency marker OCT-
4 in 6-day treated embryoid bodies (EBs) compared to control. We also showed that SB 
effectively downregulated NODAL gene expression in EBs. Further analysis showed a 
significant upregulation of NESTIN (3.7 fold) in SB treated EBs compared to control. 
Activin/Nodal pathway is important for maintenance of pluripotency and blocking this 
pathway lead to neuroectoderm differentiation (Vallier et al., 2005, Smith et al., 2008). 
Downregulation of the NODAL gene shows that SB effectively blocks the Activin/Nodal 
pathway and disturbs the pluripotency. Consistent with previous studies, we showed that SB 
not only caused downregulation of OCT-4 but also induced neural differentiation (Smith et 
al., 2008, Patani et al., 2009).  
Previously, SB treatment alone has been shown to induce neural cells with dorsal identity of 
caudal neuraxis, identified by the expression of PAX7 (Patani et al., 2009). It has been 
discussed earlier that auditory neurons are developed from the otic placodal derivative, next 
to hindbrain and PAX7 is a marker for hindbrain during development. With this assumptions, 
we hypothesized that SB treatment could induce genes responsible for auditory like sensory 
neurons. Our results showed that SB treatment indeed upregulated key genes, NGN1 (7.6 
fold), NEUROD1 (5.4 fold) and BRN3A (6.7 fold), important for development of auditory 
like sensory neurons.   
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Basic fibroblast growth factor (bFGF) has been shown to induce neuroectoderm proliferation 
as well as to act as a neurotropic factor for neuronal survival and differentiation. Some studies 
have also shown that fibroblast growth factor (FGF) signaling is important for otic placod 
induction (Martin and Groves, 2006, Freter et al., 2008) and ligand FGF3 and FGF10 are 
critical in inner ear development (Alvarez et al., 2003). FGF signaling can be activated by 
bFGF since it activates several FGF receptors including FGF3 and FGF10 (Groves and 
Bronner-Fraser, 2000). In the next step, we cultured EBs as adherent cultures in the presence 
of basic fibroblast growth factor (bFGF). This step further induced the expression of NGN1 
(25 fold), NEUROD1 (45 fold) and BRN3A (10 fold). Interestingly, we have also observed a 
significant induction of GATA3 (5 fold) in initial SB treated cultures. Further analysis by 
immunostaining showed that frequency of BRN3A/TUJ1 and ISL1/TUJ1 positive colonies 
were significantly increased in SB treated cultures in presence of bFGF compared to control. 
The results show that cultures have heterogeneous population with early progenitor and early 
mature population.  
We then assessed the number of positive cells for ISL1/TUJ1 and BRN3A/TUJ1 by 
immunocytochemistry on cells cultured in the presence of BDNF and NT-3. ISL1 expression 
can be detected in developing sensory neurons as well as in motor neurons and interneurons 
(Liang et al., 2011, Radde-Gallwitz et al., 2004).   
We observed that all colonies were positive for ISL1/TUJ1 in SB treated cultures compared to 
control. Moreover, BRN3A/TUJ1 staining showed a significant increase in the number of 
colonies (90%) in SB treated cultures compared to control. This showed that the 
neurotrophins BDNF/NT-3 provided a survival effect as well as promoted further 
differentiation into auditory like sensory neurons.  
In this study, we also used insulin like growth factor-1 (IGF-1) to indicate sensory neural 
induction. Previously, it has been shown that IGF-1 plays an important role in inner ear 
development in murine (Okano et al., 2011) and some studies have also shown the effect of 
IGF-1 in the induction of inner ear cell types, particularly hair cells, from stem cells (Li et al., 
2003, Higashi et al., 2007, Oshima et al., 2010). This was, however, not investigated in thjs 
study. Our study, in line with previous studies, showed no significant impact on 
differentiation of auditory like sensory neurons from stem cells (Chen et al., 2012) and 
human fetal auditory stem cells (Chen et al., 2009). 
Based on these results, we conclude that SB treatment has impact on early induction of 
sensory neural genes in EBs, which can be further enhanced by subsequent culture in the 
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presence of neurotrophic factors, bFGF and later BDNT/NT-3. This protocol showed the 
appropriate differentiation of markers for auditory like sensory neurons from pluripotent stem 
cells.  
4.3 PAPER III 
Induction of sensory neurons from neuroepithelial stem cells by the ISX9 small molecule 
Efficient modulation of stem cell differentiation is very crucial to translate stem cell therapies 
from bench to clinics. There has been great interest in small molecules for modulating stem 
cells into particular cell lineages (Xu et al., 2013). In this study, we used three small 
molecules, SB431542 (SB), Isoxazole 9 (ISX9) and Metformin (MET), on long-term self-
renewing neuroepithelial stem cells (Lt-NES) lines (C1GFP and AF22).  
By selecting the ISX9 small molecule, we aimed to direct the cells to differentiate into neural 
cell types by inducing the NEUROD1 gene (Schneider et al., 2008). It is known that 
NEUROD1 expression guide early neural progenitor into auditory like sensory neurons 
during development. SB has been used widely to induce neural differentiation, either alone or 
in combination with other small molecules (Chambers et al., 2009, Chambers et al., 2012, 
Patani et al., 2009, Smith et al., 2008). MET (a first line drug for diabetics) has been shown to 
promote neural differentiation in mouse embryonic cortical radial precursors (Wang et al., 
2012). 
With the approach of using lt-NES cells we aimed to minimize the presence of cells from 
mesoderm and endoderm. Lt-NES cells lines are derived from manually selected neural 
rosettes and expanded as single cell long time culture systems maintaining neural progenitor 
identity with capacity to differentiate into different types of neurons like dopaminergic 
neurons, motor neurons and cholinergic neurons (Zhang et al., 2014, Fujimoto et al., 2012, 
Falk et al., 2012). 
The ISX9 dose was titrated for our cell lines as it has been shown that the optimal doses vary 
between different cells lines (Schneider et al., 2008). Our initial experiments showed that 
proliferation decreased and apoptosis increased with increasing doses of ISX9. Isoxazole 9 
has been shown to induce neural differentiation by directly activating the NEUROD1 gene in 
mouse hippocampal neural stem cells (Schneider et al., 2008). Our dose response 
experiments showed significant reduction of NEUROD1 expression but we observed dose 
dependent increased in GATA3 expression, which is activated downstream of NEUROD1, 
 32 
and showed a significant increased at the 20µM and 40µM doses. These results abstruse our 
initial idea of activating NEUROD1 and suggested further kinetic analysis to explore 
NEUROD1 expression in ISX9 treated cells. Based on the dose response we selected a ISX9 
dose of 20µM. Optimal doses for SB (10µM) and MET (500µM) have been shown 
previously and the same doses were used in this study (Wang et al., 2012, Guo et al., 2013, 
Smith et al., 2008). 
Pattern of gene expression revealed differentiation of sensory like neurons in the ISX9 treated 
group. ISX9 treatment resulted in a significant increase in the mRNA expression of GATA3 
(25 fold), BRN3A (5.5 fold) and PERIPHERIN (27 fold) compared to control in C1GFP cell 
line. In the AF22 cell line, the effects were even more prominent: GATA3 (230 fold increase), 
BRN3A (7 fold increase) and PERIPHERIN (28 fold increase). In both C1GFP and AF22 cell 
lines immunocytochemistry revealed significantly higher numbers of BRN3A/TUJ1 positive 
cells in the ISX9 treated cultures (16% vs 22%) compared to control (4% vs 8%), 
respectively.  
Further, our results suggested that SB and MET were not effective to induced sensory neural 
differentiation in lt-NES cells lines. Interestingly, while this indicates that SB molecules are 
inadequate for sensory neural differentiation in the lt-NES cells, in Paper II we have shown 
that SB treatment can have a significant impact on early induction of sensory neural genes in 
EBs from the pluripotent hESC line HS181. 
Next, we cultured cells treated with small molecules in BDNF/NT-3 containing medium to 
test further differentiation into sensory neurons. The neurotrophins BDNF and NT-3 are 
important for the survival of sensory neurons. Our data showed a further increase in GATA3 
expression in ISX9 (8 fold vs 60 fold) treated cultures in both the cells lines, CIGFP and 
AF22 respectively (figure 3.6 A). We also observed a further increase in BRN3A/TUJ1 
positive cells in ISX9 treated cultures (23% vs 28% in C1GFP and AF22, respectively). 
Protein and mRNA data suggest that more mature nature of sensory neurons in cultures since 
GATA3 and Brn3a expression is present in late stages of auditory neuron during 
development.  
In summary, we show that the ISX9 small molecule could differentiate lt-NES cells into cells 
with auditory-like sensory neuron phenotypes. This approach could further enhance the 
availability of neurons appropriate for a cell therapy approach for sensorineural hearing loss. 
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5 GENERAL DISCUSSION 
This thesis investigated different strategies to induce sensory neurons from stem cells to be 
considered for future inner ear cell therapy. Chemical approaches using various types of 
small molecules are today central components of many differentiation protocols for stem cells 
(reviewed in (Li et al., 2013, Xu et al., 2013)). In Papers II and III we tested the small 
molecule SB431542 (inhibitor of Activin/Nodal signaling pathway by blocking 
phosphorylation of ALK4, 5, and 7 receptors), In Paper III we tested Isoxazole 9 (inducing 
NEUROD1 gene) and Metformin (a first line diabetic drug) (in paper III). In line with 
previous studies, our results showed neural induction in SB431542 treated cells (Patani et al., 
2009, Smith et al., 2008). In previous studies, SB431542 has been used in combination of 
other small molecules to differentiate hESC into peripheral sensory neurons (Kreitzer et al., 
2013, Denham et al., 2015). Very recently, it has been shown that a combination of 
SB431542 and noggin applied at appropriate time points can enhance placodal derivatives 
from hESC (Dincer et al., 2013). In paper II, we have shown that SB431542 alone is 
sufficient to induce expression of early markers of sensory neural progenitor cells from 
hESC. However, no alteration in expression of these markers was observed in lt-NES cells 
when treated with SB431542 (paper III). Several previous studies on Lt-NES cells imply that 
lt-NES cells are already programmed to differentiate into CNS type neurons (Falk et al., 
2012, Fujimoto et al., 2012, Koch et al., 2009, Zhang et al., 2014). On the other hand, we 
found that the small molecule ISX9 could induce expression of sensory neuron markers in lt-
NES cells (Paper III). ISX9 has been reported to induce neural differentiation by activation of 
NEUROD gene (Schneider et al., 2008).  Interestingly, we did not observe any change in 
NEUROD1 mRNA expression level. However, an upregulation of NEUROD1 downstream 
genes, BRN3A and GATA3, was observed after application of ISX9.   
Our findings with expression of genes involved in sensory neuron development in ISX9 
treated NES suggest that NES cells could in fact be appropriate for sensory neuron 
replacement. When we investigated the growth and integration of these cells in organotypic 
cultures with organ of Corti and spiral ganglion explants on plastic surface, our preliminary 
data showed that ISX9 treated cells not only differentiated into neurons, but also migrated 
and sent their projections towards spiral ganglion and hair cells in the organ of Corti (Figure 
5; unpublished date). Further experiments are needed to investigate migration, possible 
synaptic connections, and differentiation into sensory neurons.    
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In paper II, we modified our approach and allowed hESC to differentiate into neuroectoderm 
by blocking mesodermal and endodermal differentiation using the small molecule SB431542. 
We showed that NODAL and OCT-4 expression was reduced but our data did not confirm the 
absence of other germ layers. We could expect an unknown (likely small) percentage of cells 
to be present from mesoderm and endoderm lineages in our initial cultures and also the 
presence of different types of neurons in our final mixed cell populations.  In future studies it 
is important to perform co-expression of lineage specific markers during all steps towards the 
identified pool of cells. The same genes are expressed in different cell populations during 
different stages of development or differentiation e.g., NGN1 expression has been observed in 
sensory neurons from PNS and placodal derivatives. NEUROD1 expression is present in 
early developing neurons in embryonic nervous system as well as otic placodal cells and 
some pancreatic progenitors. ISL1 is expressed in sensory neurons as well by motor neurons 
during development. 
For paper III, we used neuroepithelial stem cells to minimize the presence of cells from 
mesoderm and endoderm. Using the ISX9 small molecule, we obtained a pattern of gene 
expression indicating strong differentiation into sensory like neurons. However, since lt-NES 
cells used in this study are prone to differentiate into different types of neurons we could 
expect also the presence of different CNS types neurons in this population. Further studies are 
needed to confirm whether the obtained sensory like neurons are gluamatergic and 
electrophysiologically active. Future studies should also address survival and integration of 
these neural cells within cochlea and spiral ganglion using transplantation in animal models.  
Based on previous studies from our group, we hypothesized that the appropriate neural 
progenitor cells are required for the successful replacement of degenerating sensory neurons 
in the cochlea in order to restore hearing and have beneficial effects, for example in 
combination with cochlear implants. Previously, three different types of cells or tissues were 
transplanted into the animal cochlea: adult neural stem cells, mouse ES cells and dorsal root 
ganglion (DRG) tissue (reviewed in (Ulfendahl et al., 2007, Hu and Ulfendahl, 2006)). 
Survival of DRG neurons were observed up to 10 weeks following transplantation, however 
the survival rate decreased with time (Hu et al., 2004b). The survival of adult neural stem 
cells and mouse ES were considerably lower as compared to DRG when implanted in the 
inner ear (Hu et al., 2005b, Hu et al., 2004a, Hu et al., 2005a). Interestingly, differentiation of 
transplanted stem cells into neurons was seen in the implanted cochlea but the occurrence 
ratio was very low.  
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Previously, Novozhilova et al. have reported that human neural progenitor cells, when co-
cultured with brainstem tissue, differentiate and extend neurites towards the brainstem 
(Novozhilova et al., 2013). From the results obtained in Paper I we selected the NS7+1week 
protocol for further studies regarding growth and differentiation of this cell populations in 
conditioned medium derived from i) brainstem, ii) organ of Corti cultures, or iii) spiral 
ganglion cultures. Photos were taken from cultures at day 0, 3 and 7 and assessed by ocular 
inspection. These experiments showed that while all conditioned medium sources stimulated 
growth and migration, spiral ganglion medium exhibited the strongest stimulatory effect, 
compared to control medium (Figure 6; unpublished data).  Most pronounced differentiation 
was obtained on day 7 with also longest neuritis growing in bundles (fascicles) (Figure 7; 
unpublished data).  
We next tested organotypic cultures using membrane inserts and co-cultured NS7 cells with 
brainstem, organ of Corti, or spiral ganglion tissue. This resulted in extensive differentiation 
but the results were not conclusive due to technical challenges. No neurites were seen 
extended on the membrane inserts (Figure 8; unpublished data). Neurites did not extend 
towards the host tissue and instead mainly grew within the NS7 colonies, or if in close 
contact with host tissue within this tissue. Further experiments are needed to establish an 
appropriate protocol to test the growth and integration of sensory neural progenitor with the 












FIGURES; Unpublished data. 
 
Figure 5: Innervation by neurite fibers from ISX9 treated NES sphere to the cochlear explant.  
NES cell spheres were made from single cells using AggreWell plates one day before. The cochlear explants 
were prepared from 3-4 days old rat and cultured on membrane inserts coated with polyornathine and laminin. 
NES spheres were placed next to the explant on the spiral ganglion side and cultured in presence of NT3 and 
BDNF (10 ng/ml). After 1 week, the cultures were fixed and processed for immunocytochemistry for 
Neurofilament 200 (red), GFP (green) and myosin VII (blue) to identify neurite fibers, NES cells and hair cells 
respectively. The representative confocal image shows that the fibers generated from the NES cells innervate the 
explant and reach both hair cells and spiral ganglion neurons. (Ali et al., unpublished) 
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Figure 6: Migration of NS7 cells following culture in auditory tissue conditioned medium.  
To study the effects of secreted molecules from different tissues of auditory system, the NS7 colonies were 
grown in the presence of conditioned medium from brainstem (BSCM), organ of Corti (OCCM) or spiral 
ganglion (SGNCM). The colonies from the different conditions were imaged on day 0, 3 and 7th day (A). 
Quantification of migration at days 0, 3 and 7 were performed by measuring the diameters of the spheres 
surrounded by the rim of migrating cells, illustrated here in a time course graph (B). The colonies showed  
similar size in all conditions on Day 0. Data represent 4 independent experiments with a total of >33 NS7 






Figure 7: Enhanced neurite outgrowth from NS7 cells induced by conditioned medium.  
(A) The NS7 colonies were grown in the presence of conditioned medium from brainstem (BSCM), organ of 
Corti (OCCM) or spiral ganglion (SGNCM) for 7 days. The colonies were then fixed, immunostained for the 
neuronal marker beta-tubulin III (green), and for DAPI (blue). (B) The colonies were imaged and neurite lengths 
measured by plotting a straight line from tip of neurite till the edge of the colony cell mass. Six to eight colonies 
were examined for each condition. * P < 0.001. (Dash-Wagh et al., unpublished) 
 
 
Figure 8: Differentiation of NS7 when co-cultured with auditory tissues.  
The NS7 were co-cultured with brainstem (A), SGN explant (B) or organ of Corti (C) for 7 days. The cultures 
then stained for ß-tubulin III (green) or human nuclei (red). (Ali et al., unpublished) 
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6 CONCLUSIONS AND FUTURE PERSPECTIVES 
The results reported in this thesis emphasize hESC and lt-NES cells for modeling auditory 
like sensory neural differentiation. By using small molecules, hESC and neuroepithelial stem 
cells could be induced to candidate cell populations for future therapy studies for 
sensorineural hearing loss. Lessons learned include that small molecules are useful for initial 
induction of differentiation into neural and sensory neural progenitors as they can suppress 
hESC to differentiate into other cells lineages. Although our results suggest the induction of 
sensory neurons from hESC and lt-NES cells, it is important to further characterize the 
different cell population in the culture system. Appropriate time points are crucial and future 
studies must ensure that the cells are well differentiated into particular lineages and not mixed 
with pluripotent or other cell lineages.  
Contrary to pluripotent stem cell, Lt-NES cells lack the potency to cause teratoma in vivo and 
are thus attractive for cell transplantations. Although, Lt-NES cells express mostly CNS types 
markers they can, as demonstrated here, be induced to express sensory neural linage markers 
by using ISX9 molecules. This could be a potential source for obtaining cells for inner ear 
cell therapy.  
The differentiated neurons should next be characterized electrophysiologically to demonstrate 
potential for functional integration within the host tissue. Our preliminary studies with ISX9 
treated cells showed signs of integration within organ of Corti but further experiments are 
needed with also other tissues to confirm these observations. These cells should also be 
transplanted into appropriate deafened animal models to explore the survival in the host 
environment, integration with host cells at the molecular level, and finally to demonstrate an 
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